The rapid microbiology testing market is booming, projected to reach $12 billion by 2033, driven by infectious disease prevalence and advanced technologies like PCR and MALDI-TOF. Learn about market trends, key players (Abbott, BD, Thermo Fisher), and future growth projections in this in-depth analysis.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.